Clinuvel Pharmaceuticals
CUV.AX
#6818
Rank
NZ$0.75 B
Marketcap
$15.00
Share price
-0.80%
Change (1 day)
-10.71%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2023: NZ$50.51 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$51.84 Million. In 2023 the company made an earning of NZ$50.51 Million, an increase over its 2022 earnings that were of NZ$39.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual earnings

Year Earnings Change
2023NZ$50.51 M27.77%
2022NZ$39.53 M22.23%
2021NZ$32.34 M114.01%
2020NZ$15.11 M-29.03%
2019NZ$21.29 M32.76%
2018NZ$16.04 M75.24%
2017NZ$9.15 M-332.09%
2016-NZ$3.95 Million-70.52%
2015-NZ$13.38 Million53.56%
2014-NZ$8.72 Million-16.31%
2013-NZ$10.42 Million-37.85%
2012-NZ$16.75 Million-18%
2011-NZ$20.43 Million25.86%
2010-NZ$16.23 Million-21.79%
2009-NZ$20.76 Million-11.73%
2008-NZ$23.51 Million80.71%
2007-NZ$13.01 Million-2.86%
2006-NZ$13.4 Million-4.95%
2005-NZ$14.1 Million60.55%
2004-NZ$8.78 Million97.37%
2003-NZ$4.45 Million50.62%
2002-NZ$2.96 Million121.22%
2001-NZ$1.34 Million254.48%
2000-NZ$0.38 Million